Found: 25
Select item for more details and to access through your institution.
Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z
- By:
- Publication type:
- Article
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. e833, doi. 10.1016/j.cllc.2021.04.007
- By:
- Publication type:
- Article
Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L).
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Phase II Study of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer who Responded to Prior PD-1/L1 Inhibitors: West Japan Oncology Group 9616L (WJOG9616L).
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2897-6
- By:
- Publication type:
- Article
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 9, p. 2109, doi. 10.1007/s00262-022-03141-4
- By:
- Publication type:
- Article
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2290, doi. 10.3390/cancers13102290
- By:
- Publication type:
- Article
Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
- By:
- Publication type:
- Article
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.6839
- By:
- Publication type:
- Article
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single‐plex testing: WJOG13620L.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21097, doi. 10.1002/cam4.6668
- By:
- Publication type:
- Article
Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 20, p. 3743, doi. 10.1002/cam4.4750
- By:
- Publication type:
- Article
Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 6, p. 2122, doi. 10.1002/cam4.2846
- By:
- Publication type:
- Article
Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168465
- By:
- Publication type:
- Article
Enteral Nutrition Is a Risk Factor for Airway Complications in Subjects Undergoing Noninvasive Ventilation for Acute Respiratory Failure.
- Published in:
- Respiratory Care, 2017, v. 62, n. 4, p. 459, doi. 10.4187/respcare.05003
- By:
- Publication type:
- Article
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1783, doi. 10.1038/s41416-024-02662-2
- By:
- Publication type:
- Article
Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
- By:
- Publication type:
- Article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10467-w
- By:
- Publication type:
- Article
Immune‐Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. e679, doi. 10.1634/theoncologist.2019-0299
- By:
- Publication type:
- Article
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 1940, doi. 10.1002/cncr.32749
- By:
- Publication type:
- Article
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L.
- Published in:
- Cancer Science, 2022, v. 113, n. 1, p. 221, doi. 10.1111/cas.15176
- By:
- Publication type:
- Article
CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50.
- Published in:
- Cancer Science, 2021, v. 112, n. 1, p. 72, doi. 10.1111/cas.14705
- By:
- Publication type:
- Article
Comparison of Systemic Inflammatory Response Syndrome and quick Sequential Organ Failure Assessment scores in predicting bacteremia in the emergency department.
- Published in:
- Acute Medicine & Surgery, 2021, v. 8, n. 1, p. 1, doi. 10.1002/ams2.654
- By:
- Publication type:
- Article
Methotrexate myelopathy with extensive transverse necrosis: Report of an autopsy case.
- Published in:
- Neuropathology, 2014, v. 34, n. 6, p. 547, doi. 10.1111/neup.12135
- By:
- Publication type:
- Article